PMID: 1053530Apr 1, 1976Paper

Treatment of the bradycardia-tachycardia syndrome with permanent demand pacing

D E Pittman


The bradycardia-tachycardia syndrome (paroxysmal supraventricular tachycardia alternating with sinus bradycardia and episodes of sinus node arrest) has previously presented a complicated therapeutic dilemma when excitatory and suppressive drugs have been utilized. A patient with this syndrome successfully treated with a permanent ventricular transvenous demand pacemaker is presented. Various aspects of this syndrome as well as facets of diagnosis and treatment have been reviewed and discussed. Significant underlying cardiac disease was ruled out in this patient by the usual diagnostic methods including left heart catheterization and coronary angiography. An interesting possibility of the relationship of vagal stimulation secondary to hiatus hernia as an etiologic factor in this syndrome has been discussed. The opinion is expressed that the currently preferred method of treatment is the insertion of a permanent transvenous pacemaker alone or in conjunction with antiarrhythmic drugs, preferably digitalis and propranolol.


Nov 1, 1967·The American Journal of Cardiology·T N James
Mar 1, 1968·American Heart Journal·E M McNally, A Benchimol
Sep 1, 1968·The American Journal of Cardiology·T N James, L Sherf
Aug 1, 1969·The Annals of Thoracic Surgery·N P Smyth
Jun 1, 1970·The American Journal of Cardiology·S S Barold, J W Linhart
Oct 22, 1970·The New England Journal of Medicine·B Lown, B D Kosowsky
Nov 1, 1969·Archives of Internal Medicine·N P ChawlaW Shapiro
Jan 1, 1970·British Heart Journal·R RoksethP O Foss
Oct 1, 1970·The American Journal of Cardiology·W J Kostuk, D S Beanlands
Mar 1, 1968·Annals of Internal Medicine·D P ZipesA G Wallace
Nov 1, 1968·The American Journal of Cardiology·N A DeFrancis, R P Giordano
Sep 2, 1968·JAMA : the Journal of the American Medical Association·R H GoetzB Berkovits
May 1, 1969·Annals of Internal Medicine·D P ZipesW L Floyd
Apr 1, 1969·Archives of Internal Medicine·J A Murray
Sep 1, 1966·Progress in Cardiovascular Diseases·W M ChardackW Greatbatch
Nov 1, 1967·The American Journal of Cardiology·H E CohenE Donoso
Apr 1, 1954·British Heart Journal·D S SHORT
Nov 1, 1964·The American Journal of Medicine·M LEV
Nov 1, 1951·The American Journal of Physiology·J C SCOTT, E A REED
Apr 1, 1945·British Heart Journal·R S Pearson
Nov 1, 1960·British Heart Journal·J B McGuinness, S D Park
Sep 2, 1967·British Medical Journal·E Sowton
Mar 1, 1946·Proceedings of the Society for Experimental Biology and Medicine·D SCHERF

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.


Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.